Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, August 29, 2012

Roles of the Akt substrate Girdin in cancer progression, angiogenesis and neurogenesis.

We need angiogenesis and neurogenesis and Akt to help cell migration.  Have Akt lasso those newborn neurons and drag them to the correct spot.
http://w3serv.nagoya-u.ac.jp/coemed/en/meetings/meetings/international/dr-masahide-takahashi-1/
The serine/threonine kinase Akt is involved in a variety of cellular processes including cell proliferation, survival and gene expression. Akt has also been shown to be required for cell migration in different organisms. However, the mechanism by which Akt functions to promote cell migration is not fully understood. We identified a new Akt substrate, Girdin (girders of actin filament) which is an actin-binding protein, and found that Girdin is essential for the integrity of the actin cytoskeleton and cell migration. Girdin is expressed in immature endothelial cells, neuronal cells and some types of cancer cells, such as breast cancer and glioblastoma. Akt phosphorylates serine at position 1416 in Girdin, and phosphorylated Girdin accumulates at the leading edge of migrating cells. Cells expressing mutant Girdin, in which serine 1416 was replaced with alanine, exhibited limited migration and lamellipodia formation. Girdin-deficient mice exhibited neuronal migration defect which results in hypoplasia of the olfactory bulb and granule cell dispersion in the dentate gyrus. In addition, we obtained evidence that Akt-mediated phosphorylation of Girdin promotes VEGF-dependent migration and capillary formation of endothelial cells. Depletion of Girdin also resulted in severe impairment of cancer cell migration and invasion. A significant observation is that Girdin is dispensable for cell migratory events during embryonic development. Our findings suggest that Girdin and its interacting proteins are potential pharmaceutical targets for cancer therapies and pathological angiogenesis, including tumor angiogenesis.

No comments:

Post a Comment